IBS(SH:603183)2022-10-25 16:00Financial Performance - The company's operating revenue for Q3 2022 was ¥201,531,884, a decrease of 9.41% compared to the same period last year[3]. - The net profit attributable to shareholders was ¥3,427,344, down 83.67% year-on-year, while the net profit after deducting non-recurring gains and losses was ¥1,635,462.90, a decline of 90.91%[3]. - The basic earnings per share for the period was ¥0.01, representing a decrease of 76.13% compared to the previous year[3]. - Total operating revenue for the first three quarters of 2022 was RMB 460,912,184.71, a decrease of 17.5% compared to RMB 558,658,878.20 in the same period of 2021[17]. - The net profit for Q3 2022 was CNY 12,226,267.26, a decrease from CNY 66,468,724.64 in Q3 2021, representing an 81.7% decline[19]. - The total revenue for the first nine months of 2022 was CNY 500,763,695.35, down from CNY 552,254,585.60 in the same period of 2021, indicating a decrease of approximately 9.3%[22]. - The company reported a total comprehensive income of CNY 12,226,267.26 for Q3 2022, significantly lower than CNY 66,468,724.64 in Q3 2021, marking an 81.7% drop[20]. - The basic and diluted earnings per share for Q3 2022 were both CNY 0.01, down from CNY 0.12 in Q3 2021, a decline of 91.7%[20]. Cash Flow and Liquidity - Cash flow from operating activities was negative at -¥16,889,206.40, indicating cash outflow during the period[3]. - The net cash flow from operating activities for Q3 2022 was -CNY 16,889,206.40, compared to -CNY 15,413,407.99 in Q3 2021, reflecting a worsening cash flow situation[23]. - The cash and cash equivalents at the end of Q3 2022 stood at CNY 152,011,770.96, down from CNY 229,503,522.00 at the end of Q3 2021, a decrease of about 33.8%[24]. - The company's cash and cash equivalents were CNY 21,557,625.66 as of September 30, 2022, compared to CNY 79,969,167.98 at the end of 2021, representing a decrease of about 73%[26]. - The net cash flow from operating activities for the first three quarters of 2022 was CNY 30,565,988.78, a significant increase from CNY 3,182,427.70 in the previous year[32]. - Cash inflows from investment activities in the first three quarters of 2022 amounted to CNY 20,092,420.70, down from CNY 92,481,941.02 in the same period of 2021, indicating a decrease of approximately 78.3%[33]. - The net cash flow from investment activities was -CNY 61,098,714.56 for the first three quarters of 2022, an improvement from -CNY 77,265,943.68 in the previous year[33]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,850,489,240.53, a decrease of 2.51% from the end of the previous year[4]. - Total assets as of September 30, 2022, were RMB 1,850,489,240.53, compared to RMB 1,898,149,083.08 at the end of 2021, reflecting a decrease of 2.5%[16]. - Total liabilities as of September 30, 2022, were RMB 416,431,890.78, down from RMB 458,197,770.81 at the end of 2021, a reduction of 9.1%[15]. - Total liabilities increased to CNY 510,134,424.04 from CNY 375,730,405.66, marking an increase of about 36%[28]. - The company's equity attributable to shareholders as of September 30, 2022, was RMB 1,390,642,844.88, a slight decrease from RMB 1,409,474,390.67 at the end of 2021, down by 1.3%[16]. - Owner's equity decreased to CNY 918,629,439.93 from CNY 952,243,438.01, reflecting a decline of approximately 3.5%[28]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 28,623[10]. - The top shareholder, Wu Xiaoxiang, held 7.40% of the shares, amounting to 37,055,723 shares[10]. Research and Development - Research and development expenses increased to RMB 48,292,796.40 in the first three quarters of 2022, compared to RMB 45,298,884.41 in the same period of 2021, reflecting a growth of 6.6%[17]. - Research and development expenses for the first three quarters of 2022 were CNY 3,241,593.16, slightly down from CNY 3,928,735.37 in 2021, indicating a decrease of approximately 17.5%[30]. Future Outlook - The company plans to focus on market expansion and new product development in the upcoming quarters to drive future growth[12].